Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Double-blind Randomized Placebo-controlled Trial to Assess the Efficacy of Ivermectin in Combination With Favipiravir in Mild-to-moderate COVID-19 Adult Patients

NCT05155527 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT05155527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05155527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Double-blind Randomized Placebo-controlled Trial to Assess the Efficacy of Ivermectin in Combination With Favipiravir in Mild-to-moderate COVID-19 Adult Patients
Lead sponsor
Mahidol University
Phase
Phase 2
Overall status
Unknown status
Start date
February 10, 2022
Completion date
June 30, 2022
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19